RESUMEN
The basal ganglia (BG) are involved in cognitive/motivational functions in addition to movement control. Thus, BG segregated circuits, the sensorimotor (SM) and medial prefrontal (mPF) circuits, process different functional domains, such as motor and cognitive/motivational behaviours, respectively. With a high presence in the BG, the CB1 cannabinoid receptor modulates BG circuits. Furthermore, dopamine (DA), one of the principal neurotransmitters in the BG, also plays a key role in circuit functionality. Taking into account the interaction between DA and the endocannabinoid system at the BG level, we investigated the functioning of BG circuits and their modulation by the CB1 receptor under DA-depleted conditions. We performed single-unit extracellular recordings of substantia nigra pars reticulata (SNr) neurons with simultaneous cortical stimulation in sham and 6-hydroxydopamine (6-OHDA)-lesioned rats, together with immunohistochemical assays. We showed that DA loss alters cortico-nigral information processing in both circuits, with a predominant transmission through the hyperdirect pathway in the SM circuit and an increased transmission through the direct pathway in the mPF circuit. Moreover, although DA denervation does not change CB1 receptor density, it impairs its functionality, leading to a lack of modulation. These data highlight an abnormal transfer of information through the associative/limbic domains after DA denervation that may be related to the non-motor symptoms manifested by Parkinson's disease patients.
Asunto(s)
Ganglios Basales/metabolismo , Dopamina/metabolismo , Sistema Límbico/metabolismo , Corteza Motora/metabolismo , Neuronas/metabolismo , Porción Reticular de la Sustancia Negra/metabolismo , Receptor Cannabinoide CB1/metabolismo , Potenciales de Acción/fisiología , Animales , Ganglios Basales/efectos de los fármacos , Modelos Animales de Enfermedad , Electrodos , Inmunohistoquímica , Sistema Límbico/efectos de los fármacos , Masculino , Corteza Motora/efectos de los fármacos , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/metabolismo , Neuronas/efectos de los fármacos , Oxidopamina/toxicidad , Enfermedad de Parkinson/metabolismo , Porción Reticular de la Sustancia Negra/citología , Porción Reticular de la Sustancia Negra/efectos de los fármacos , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/metabolismo , Ratas , Receptor Cannabinoide CB1/fisiología , Simpatectomía Química , Simpaticolíticos/toxicidadRESUMEN
An innocuous sensory stimulus that reliably signals an upcoming aversive event can be conditioned to elicit locomotion to a safe location before the aversive outcome ensues. The neural circuits that mediate the expression of this signaled locomotor action, known as signaled active avoidance, have not been identified. While exploring sensorimotor midbrain circuits in mice of either sex, we found that excitation of GABAergic cells in the substantia nigra pars reticulata blocks signaled active avoidance by inhibiting cells in the pedunculopontine tegmental nucleus (PPT), not by inhibiting cells in the superior colliculus or thalamus. Direct inhibition of putative-glutamatergic PPT cells, excitation of GABAergic PPT cells, or excitation of GABAergic afferents in PPT, abolish signaled active avoidance. Conversely, excitation of putative-glutamatergic PPT cells, or inhibition of GABAergic PPT cells, can be tuned to drive avoidance responses. The PPT is an essential junction for the expression of signaled active avoidance gated by nigral and other synaptic afferents.SIGNIFICANCE STATEMENT When a harmful situation is signaled by a sensory stimulus (e.g., street light), subjects typically learn to respond with active or passive avoidance responses that circumvent the threat. During signaled active avoidance behavior, subjects move away to avoid a threat signaled by a preceding innocuous stimulus. We identified a part of the midbrain essential to process the signal and avoid the threat. Inhibition of neurons in this area eliminates avoidance responses to the signal but preserves escape responses caused by presentation of the threat. The results highlight an essential part of the neural circuits that mediate signaled active avoidance behavior.
Asunto(s)
Reacción de Prevención/fisiología , Reacción de Fuga/fisiología , Neuronas GABAérgicas/fisiología , Red Nerviosa/fisiología , Porción Reticular de la Sustancia Negra/fisiología , Núcleo Tegmental Pedunculopontino/fisiología , Animales , Reacción de Prevención/efectos de los fármacos , Reacción de Prevención/efectos de la radiación , Mapeo Encefálico , Proteínas Portadoras/genética , Proteínas Portadoras/efectos de la radiación , Clozapina/análogos & derivados , Clozapina/farmacología , Condicionamiento Clásico , Dependovirus/genética , Conducta de Ingestión de Líquido , Electrochoque , Reacción de Fuga/efectos de los fármacos , Reacción de Fuga/efectos de la radiación , Mutación con Ganancia de Función , Genes Reporteros , Vectores Genéticos/administración & dosificación , Luz , Ratones , Ruido/efectos adversos , Optogenética , Porción Reticular de la Sustancia Negra/citología , Tiempo de Reacción , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/efectos de la radiación , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/efectos de la radiación , Colículos Superiores/citología , Colículos Superiores/fisiología , Tálamo/citología , Tálamo/fisiologíaRESUMEN
The changes in firing probability produced by a synaptic input are usually visualized using the poststimulus time histogram (PSTH). It would be useful if postsynaptic firing patterns could be predicted from patterns of afferent synaptic activation, but attempts to predict the PSTH from synaptic potential waveforms using reasoning based on voltage trajectory and spike threshold have not been successful, especially for inhibitory inputs. We measured PSTHs for substantia nigra pars reticulata (SNr) neurons inhibited by optogenetic stimulation of striato-nigral inputs or by matching artificial inhibitory conductances applied by dynamic clamp. The PSTH was predicted by a model based on each SNr cell's phase-resetting curve (PRC). Optogenetic activation of striato-nigral input or artificial synaptic inhibition produced a PSTH consisting of an initial depression of firing followed by oscillatory increases and decreases repeating at the SNr cell's baseline firing rate. The phase resetting model produced PSTHs closely resembling the cell data, including the primary pause in firing and the oscillation. Key features of the PSTH, including the onset rate and duration of the initial inhibitory phase, and the subsequent increase in firing probability could be explained from the characteristic shape of the SNr cell's PRC. The rate of damping of the late oscillation was explained by the influence of asynchronous phase perturbations producing firing rate jitter and wander. Our results demonstrate the utility of phase-resetting models as a general method for predicting firing in spontaneously active neurons and their value in interpretation of the striato-nigral PSTH. NEW & NOTEWORTHY The coupling of patterned presynaptic input to sequences of postsynaptic firing is a Gordian knot, complicated by the multidimensionality of neuronal state and the diversity of potential initial states. Even so, it is fundamental for even the simplest understanding of network dynamics. We show that a simple phase-resetting model constructed from experimental measurements can explain and predict the sequence of spike rate changes following synaptic inhibition of an oscillating basal ganglia output neuron.
Asunto(s)
Inhibición Neural , Porción Reticular de la Sustancia Negra/fisiología , Potenciales Sinápticos , Animales , Ganglios Basales/citología , Ganglios Basales/fisiología , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , Neuronas/fisiología , Optogenética , Porción Reticular de la Sustancia Negra/citologíaRESUMEN
Neurons use glucose to fuel glycolysis and provide substrates for mitochondrial respiration, but neurons can also use alternative fuels that bypass glycolysis and feed directly into mitochondria. To determine whether neuronal pacemaking depends on active glucose metabolism, we switched the metabolic fuel from glucose to alternative fuels, lactate or ß-hydroxybutyrate, while monitoring the spontaneous firing of GABAergic neurons in mouse substantia nigra pars reticulata (SNr) brain slices. We found that alternative fuels, in the absence of glucose, sustained SNr spontaneous firing at basal rates, but glycolysis may still be supported by glycogen in the absence of glucose. To prevent any glycogen-fueled glycolysis, we directly inhibited glycolysis using either 2-deoxyglucose or iodoacetic acid. Inhibiting glycolysis in the presence of alternative fuels lowered SNr firing to a slower sustained firing rate. Surprisingly, we found that the decrease in SNr firing was not mediated by ATP-sensitive potassium (KATP) channel activity, but if we lowered the perfusion flow rate or omitted the alternative fuel, KATP channels were activated and could silence SNr firing. The KATP-independent slowing of SNr firing that occurred with glycolytic inhibition in the presence of alternative fuels was consistent with a decrease in a nonselective cationic conductance. Although mitochondrial metabolism alone can prevent severe energy deprivation and KATP channel activation in SNr neurons, active glucose metabolism appears important for keeping open a class of ion channels that is crucial for the high spontaneous firing rate of SNr neurons.
Asunto(s)
Potenciales de Acción/fisiología , Neuronas GABAérgicas/fisiología , Canales KATP/fisiología , Neuronas/metabolismo , Porción Reticular de la Sustancia Negra/citología , Porción Reticular de la Sustancia Negra/fisiología , Canales de Potencial de Receptor Transitorio/fisiología , Ácido 3-Hidroxibutírico/metabolismo , Animales , Desoxiglucosa/farmacología , Femenino , Glucólisis/efectos de los fármacos , Glucólisis/fisiología , Ácido Yodoacético/farmacología , Ácido Láctico/metabolismo , Masculino , RatonesRESUMEN
The substantia nigra pars reticulata (SNr) is a major output nucleus of the basal ganglia circuitry particularly sensitive to pathological dopamine depletion. Indeed, hyperactivity of SNr neurons is known to be responsible for some motor disorders characteristic of Parkinson's disease. The neuronal processing of basal ganglia dysfunction is well understood but, paradoxically, the role of astrocytes in the regulation of SNr activity has rarely been considered. We thus investigated the influence of the disruption of dopaminergic transmission on plastic changes at tripartite glutamatergic synapses in the rat SNr and on astrocyte calcium activity. In 6-hydroxydopamine-lesioned rats, we observed structural plastic changes of tripartite glutamatergic synapses and perisynaptic astrocytic processes. These findings suggest that subthalamonigral synapses undergo morphological changes that accompany the pathophysiological processes of Parkinson's disease. The pharmacological blockade of dopaminergic transmission (with sulpiride and SCH-23390) increased astrocyte calcium excitability, synchrony and gap junction coupling within the SNr, suggesting a functional adaptation of astrocytes to dopamine transmission disruption in this output nucleus. This hyperactivity is partly reversed by subthalamic nucleus high-frequency stimulation which has emerged as an efficient symptomatic treatment for Parkinson's disease. Therefore, our results demonstrate structural and functional reshaping of neuronal and glial elements highlighting a functional plasticity of neuroglial interactions when dopamine transmission is disrupted.
Asunto(s)
Astrocitos/metabolismo , Dopamina/metabolismo , Porción Reticular de la Sustancia Negra/citología , Porción Reticular de la Sustancia Negra/metabolismo , Sinapsis/patología , Transmisión Sináptica/efectos de los fármacos , Animales , Astrocitos/efectos de los fármacos , Astrocitos/patología , Benzazepinas/farmacología , Calcio/metabolismo , Señalización del Calcio/efectos de los fármacos , Ácido Glutámico/metabolismo , Masculino , Oxidopamina/toxicidad , Porción Reticular de la Sustancia Negra/lesiones , Porción Reticular de la Sustancia Negra/patología , Ratas , Sulpirida/farmacología , Sinapsis/metabolismoRESUMEN
Gaze is strongly attracted to visual objects that have been associated with rewards. Key to this function is a basal ganglia circuit originating from the caudate nucleus (CD), mediated by the substantia nigra pars reticulata (SNr), and aiming at the superior colliculus (SC). Notably, subregions of CD encode values of visual objects differently: stably by CD tail [CD(T)] vs. flexibly by CD head [CD(H)]. Are the stable and flexible value signals processed separately throughout the CD-SNr-SC circuit? To answer this question, we identified SNr neurons by their inputs from CD and outputs to SC and examined their sensitivity to object values. The direct input from CD was identified by SNr neuron's inhibitory response to electrical stimulation of CD. We found that SNr neurons were separated into two groups: 1) neurons inhibited by CD(T) stimulation, located in the caudal-dorsal-lateral SNr (cdlSNr), and 2) neurons inhibited by CD(H) stimulation, located in the rostral-ventral-medial SNr (rvmSNr). Most of CD(T)-recipient SNr neurons encoded stable values, whereas CD(H)-recipient SNr neurons tended to encode flexible values. The output to SC was identified by SNr neuron's antidromic response to SC stimulation. Among the antidromically activated neurons, many encoded only stable values, while some encoded only flexible values. These results suggest that CD(T)-cdlSNr-SC circuit and CD(H)-rvmSNr-SC circuit transmit stable and flexible value signals, largely separately, to SC. The speed of signal transmission was faster through CD(T)-cdlSNr-SC circuit than through CD(H)-rvmSNr-SC circuit, which may reflect automatic and controlled gaze orienting guided by these circuits.
Asunto(s)
Conectoma , Porción Reticular de la Sustancia Negra/fisiología , Desempeño Psicomotor , Animales , Macaca mulatta , Masculino , Inhibición Neural , Neuronas/fisiología , Porción Reticular de la Sustancia Negra/citologíaRESUMEN
The arousal state of the brain covaries with the motor state of the animal. How these state changes are coordinated remains unclear. We discovered that sleep-wake brain states and motor behaviors are coregulated by shared neurons in the substantia nigra pars reticulata (SNr). Analysis of mouse home-cage behavior identified four states with different levels of brain arousal and motor activity: locomotion, nonlocomotor movement, quiet wakefulness, and sleep; transitions occurred not randomly but primarily between neighboring states. The glutamic acid decarboxylase 2 but not the parvalbumin subset of SNr γ-aminobutyric acid (GABA)-releasing (GABAergic) neurons was preferentially active in states of low motor activity and arousal. Their activation or inactivation biased the direction of natural behavioral transitions and promoted or suppressed sleep, respectively. These GABAergic neurons integrate wide-ranging inputs and innervate multiple arousal-promoting and motor-control circuits through extensive collateral projections.
Asunto(s)
Neuronas GABAérgicas/fisiología , Actividad Motora/fisiología , Porción Reticular de la Sustancia Negra/fisiología , Sueño/fisiología , Vigilia/fisiología , Animales , Mapeo Encefálico , Femenino , Neuronas GABAérgicas/metabolismo , Glutamato Descarboxilasa/metabolismo , Masculino , Ratones , Ratones Mutantes , Optogenética , Porción Reticular de la Sustancia Negra/citología , Parvalbúminas/metabolismoRESUMEN
In the basal ganglia (BG), anatomically segregated and topographically organized feedforward circuits are thought to modulate multiple behaviors in parallel. Although topographically arranged BG circuits have been described, the extent to which these relationships are maintained across the BG output nuclei and in downstream targets is unclear. Here, using focal trans-synaptic anterograde tracing, we show that the motor-action-related topographical organization of the striatum is preserved in all BG output nuclei. The topography is also maintained downstream of the BG and in multiple parallel closed loops that provide striatal input. Furthermore, focal activation of two distinct striatal regions induces either licking or turning, consistent with their respective anatomical targets of projection outside of the BG. Our results confirm the parallel model of BG function and suggest that the integration and competition of information relating to different behavior occur largely outside of the BG.
Asunto(s)
Ganglios Basales/citología , Ganglios Basales/fisiología , Conducta Animal/fisiología , Neuronas/fisiología , Animales , Corteza Cerebral/fisiología , Femenino , Núcleos Talámicos Intralaminares/citología , Núcleos Talámicos Intralaminares/fisiología , Masculino , Ratones Endogámicos C57BL , Vías Nerviosas/citología , Vías Nerviosas/fisiología , Técnicas de Trazados de Vías Neuroanatómicas , Porción Reticular de la Sustancia Negra/citología , Porción Reticular de la Sustancia Negra/fisiología , Colículos Superiores/citología , Colículos Superiores/fisiología , Núcleos Talámicos Ventrales/citología , Núcleos Talámicos Ventrales/fisiologíaRESUMEN
Fronto-striatal circuits constitute the neurobiological basis of many neuropsychiatric disorders. Part of the intracellular signaling within these circuits, including its dopaminergic modulation, is regulated by the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling cascade. Based on the overall expression in human fronto-striatal circuitry, we tested the effects of a cAMP selective phosphodiesterase 4 (PDE4) inhibitor on the tri-phasic response in the dorsomedial substantia nigra pars reticulata (SNr) upon stimulation of the infralimbic cortex in rats. Our results show for the first time that stimulation of the cognitive infralimbic cortex leads to a tri-phasic response in SNr neurons. In addition and in line with previous biochemical and behavioral studies, PDE4 inhibition by roflumilast affects the direct pathway as well as the indirect pathway of which the latter appears more sensitive than the former.
Asunto(s)
Potenciales de Acción/efectos de los fármacos , Aminopiridinas/farmacología , Benzamidas/farmacología , Vías Nerviosas/efectos de los fármacos , Porción Reticular de la Sustancia Negra/citología , Inhibidores de Fosfodiesterasa 4/farmacología , Potenciales de Acción/fisiología , Análisis de Varianza , Animales , Ciclopropanos/farmacología , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Electrocardiografía , Masculino , Corteza Motora/fisiología , Vías Nerviosas/fisiología , Ratas , Ratas WistarRESUMEN
Cholinergic regulation of dopaminergic inputs into the striatum is critical for normal basal ganglia (BG) function. This regulation of BG function is thought to be primarily mediated by acetylcholine released from cholinergic interneurons (ChIs) acting locally in the striatum. We now report a combination of pharmacological, electrophysiological, optogenetic, chemogenetic, and functional magnetic resonance imaging studies suggesting extra-striatal cholinergic projections from the pedunculopontine nucleus to the substantia nigra pars reticulata (SNr) act on muscarinic acetylcholine receptor subtype 4 (M4) to oppose cAMP-dependent dopamine receptor subtype 1 (D1) signaling in presynaptic terminals of direct pathway striatal spiny projections neurons. This induces a tonic inhibition of transmission at direct pathway synapses and D1-mediated activation of motor activity. These studies provide important new insights into the unique role of M4 in regulating BG function and challenge the prevailing hypothesis of the centrality of striatal ChIs in opposing dopamine regulation of BG output.
Asunto(s)
Ganglios Basales/citología , Neuronas Colinérgicas/fisiología , Dopamina/metabolismo , Porción Reticular de la Sustancia Negra/fisiología , Receptor Muscarínico M4/metabolismo , Acetilcolina/metabolismo , Animales , Ganglios Basales/diagnóstico por imagen , Ganglios Basales/fisiología , Channelrhodopsins/genética , Channelrhodopsins/metabolismo , Colina O-Acetiltransferasa/metabolismo , Colinérgicos/farmacología , Neuronas Colinérgicas/efectos de los fármacos , Dopamina/farmacología , Potenciales Postsinápticos Inhibidores/efectos de los fármacos , Potenciales Postsinápticos Inhibidores/genética , Locomoción/efectos de los fármacos , Locomoción/genética , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Neurotransmisores/farmacología , Oxígeno/sangre , Porción Reticular de la Sustancia Negra/citología , Porción Reticular de la Sustancia Negra/diagnóstico por imagen , Núcleo Tegmental Pedunculopontino/citología , Receptor Muscarínico M4/genética , Receptores de Dopamina D1/genética , Receptores de Dopamina D1/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiologíaRESUMEN
OBJECTIVE: Fos protein expression in catecholamine-synthesizing neurons of the substantia nigra (SN) pars compacta (SNC, A8), pars reticulata (SNR, A9), and pars lateralis (SNL), the ventral tegmental area (VTA, A10), the locus coeruleus (LC, A6) and subcoeruleus (sLC), the ventrolateral pons (PON-A5), the nucleus of the solitary tract (NTS-A2), the area postrema (AP), and the ventrolateral medulla (VLM-A1) was quantitatively evaluated aft er a single administration of asenapine (ASE) (designated for schizophrenia treatment) in male Wistar rats preconditioned with a chronic unpredictable variable mild stress (CMS) for 21 days. Th e aim of the present study was to reveal whether a single ASE treatment may 1) activate Fos expression in the brain areas selected; 2) activate tyrosine hydroxylase (TH)-synthesizing cells displaying Fos presence; and 3) be modulated by CMS preconditioning. METHODS: Control (CON), ASE, CMS, and CMS+ASE groups were used. CMS included restraint, social isolation, crowding, swimming, and cold. Th e ASE and CMS+ASE groups received a single dose of ASE (0.3 mg/kg, s.c.) and CON and CMS saline (300 µl/rat, s.c.). The animals were sacrificed 90 min aft er the treatments. Fos protein and TH-labeled immunoreactive perikarya were analyzed on double labeled histological sections and enumerated on captured pictures using combined light and fluorescence microscope illumination. RESULTS: Saline or CMS alone did not promote Fos expression in any of the structures investigated. ASE alone or in combination with CMS elicited Fos expression in two parts of the SN (SNC, SNR) and the VTA. Aside from some cells in the central gray tegmental nuclei adjacent to LC, where a small number of Fos profiles occurred, none or negligible Fos occurrence was detected in the other structures investigated including the LC and sLC, PON-A5, NTS-A2, AP, and VLM-A1. CMS preconditioning did not infl uence the level of Fos induction in the SN and VTA elicited by ASE administration. Similarly, the ratio between the amount of free Fos and Fos colocalized with TH was not aff ected by stress preconditioning in the SNC, SNR, and the VTA. CONCLUSIONS: Th e present study provides an anatomical/functional knowledge about the nature of the acute ASE treatment on the catecholamine-synthesizing neurons activity in certain brain structures and their missing interplay with the CMS preconditioning.
Asunto(s)
Antipsicóticos/farmacología , Encéfalo/efectos de los fármacos , Condicionamiento Psicológico , Compuestos Heterocíclicos de 4 o más Anillos/farmacología , Neuronas/efectos de los fármacos , Proteínas Proto-Oncogénicas c-fos/efectos de los fármacos , Estrés Psicológico/metabolismo , Tirosina 3-Monooxigenasa/efectos de los fármacos , Animales , Área Postrema/citología , Área Postrema/efectos de los fármacos , Área Postrema/metabolismo , Encéfalo/citología , Encéfalo/metabolismo , Catecolaminas/biosíntesis , Dibenzocicloheptenos , Inmunohistoquímica , Locus Coeruleus/citología , Locus Coeruleus/efectos de los fármacos , Locus Coeruleus/metabolismo , Masculino , Bulbo Raquídeo/citología , Bulbo Raquídeo/efectos de los fármacos , Bulbo Raquídeo/metabolismo , Microscopía Fluorescente , Neuronas/metabolismo , Porción Compacta de la Sustancia Negra/citología , Porción Compacta de la Sustancia Negra/efectos de los fármacos , Porción Compacta de la Sustancia Negra/metabolismo , Porción Reticular de la Sustancia Negra/citología , Porción Reticular de la Sustancia Negra/efectos de los fármacos , Porción Reticular de la Sustancia Negra/metabolismo , Puente/citología , Puente/efectos de los fármacos , Puente/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Ratas , Ratas Wistar , Núcleo Solitario/citología , Núcleo Solitario/efectos de los fármacos , Núcleo Solitario/metabolismo , Estrés Psicológico/psicología , Tirosina 3-Monooxigenasa/metabolismo , Área Tegmental Ventral/citología , Área Tegmental Ventral/efectos de los fármacos , Área Tegmental Ventral/metabolismoRESUMEN
Sleep is an essential and conserved behavior whose regulation at the molecular and anatomical level remains to be elucidated. Here, we identify TARANIS (TARA), a Drosophila homolog of the Trip-Br (SERTAD) family of transcriptional coregulators, as a molecule that is required for normal sleep patterns. Through a forward-genetic screen, we isolated tara as a novel sleep gene associated with a marked reduction in sleep amount. Targeted knockdown of tara suggests that it functions in cholinergic neurons to promote sleep. tara encodes a conserved cell-cycle protein that contains a Cyclin A (CycA)-binding homology domain. TARA regulates CycA protein levels and genetically and physically interacts with CycA to promote sleep. Furthermore, decreased levels of Cyclin-dependent kinase 1 (Cdk1), a kinase partner of CycA, rescue the short-sleeping phenotype of tara and CycA mutants, while increased Cdk1 activity mimics the tara and CycA phenotypes, suggesting that Cdk1 mediates the role of TARA and CycA in sleep regulation. Finally, we describe a novel wake-promoting role for a cluster of â¼14 CycA-expressing neurons in the pars lateralis (PL), previously proposed to be analogous to the mammalian hypothalamus. We propose that TARANIS controls sleep amount by regulating CycA protein levels and inhibiting Cdk1 activity in a novel arousal center.
Asunto(s)
Nivel de Alerta/fisiología , Proteína Quinasa CDC2/metabolismo , Proteínas de Ciclo Celular/metabolismo , Ciclina A/metabolismo , Proteínas de Drosophila/metabolismo , Drosophila/fisiología , Sueño/fisiología , Animales , Western Blotting , Proteínas de Ciclo Celular/genética , Proteínas de Drosophila/genética , Técnicas de Silenciamiento del Gen , Neuronas/fisiología , Porción Reticular de la Sustancia Negra/citología , Porción Reticular de la Sustancia Negra/fisiología , Interferencia de ARNRESUMEN
The cortico-basal ganglia-thalamic loop circuit is involved in variety of motor, association and limbic functions. The basal ganglia receive neural information from various areas of the cerebral cortex and transfer them back to the frontal and motor cortex via the ventral medial (VM), and the anterior-ventral lateral thalamic complex. The projection from the basal ganglia to the thalamus is GABAergic, and, therefore, the output from the basal ganglia cannot directly evoke excitation in the thalamic nuclei. The mechanism underlying the information transfer via the inhibitory projection remains unclear. To address this issue, we recorded electrophysiological properties of nigro-thalamic synapses from the VM neuron. We developed a nigro-thalamic slice preparation, in which the projection from the substantia nigra pars reticulata (SNr) to VM nucleus is stored, to enable the selective activation of the projection from the SNr. We characterized synaptic properties and membrane properties of the VM neuron, and developed a VM neuron model to simulate the impacts of SNr inputs on VM neuron activity. Neural simulation suggested that the inhibitory projection from SNr can control neural activity in two ways: a disinhibition from the spontaneous nigral inhibition and a ß-band synchronization evoked by combination of excitation and inhibition of SNr activity.
Asunto(s)
Neuronas/fisiología , Porción Reticular de la Sustancia Negra/fisiología , Transmisión Sináptica , Núcleos Talámicos Ventrales/fisiología , Potenciales de Acción , Animales , Simulación por Computador , Potenciales Postsinápticos Inhibidores , Ratones , Ratones Endogámicos C57BL , Modelos Neurológicos , Vías Nerviosas/fisiología , Porción Reticular de la Sustancia Negra/citología , Núcleos Talámicos Ventrales/citologíaRESUMEN
γ-Aminobutyric acid A receptor (GABAAR)-mediated postsynaptic currents were recorded in brain slices from substantia nigra pars reticulate neurons. The selective adenosine A1 receptor (A1R) antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), increased the frequency, but not the amplitude of spontaneous inhibitory post-synaptic currents (IPSCs) in the presence of the dopamine D1 receptor agonist SKF 38393 (SKF) and phosphodiesterase 10A inhibitors (papaverine or AE90074). Under these conditions, DPCPX also increased the amplitude of evoked IPSCs (eIPSCs). The effect of DPCPX was also examined in a mouse model of Parkinson's disease (PD), generated by unilateral denervation of the dopaminergic input to the striatum. In this model, SKF alone was sufficient to increase sIPSCs frequency and eIPSCs amplitude, and these effects were not potentiated by DPCPX. To confirm a depressive effect of A1Rs on the synaptic release of GABA we used the selective A1R agonist 5'-chloro-5'-deoxy-N(6)-(±)-(endo-norborn-2-yl)adenosine (5'Cl5'd-(±)-ENBA) which has limited peripheral actions. We found that 5'Cl5'd-(±)-ENBA decreased sIPSCs frequency, without affecting their amplitude, and decreased eIPSCs amplitude. Importantly, in the PD mouse model, 5'Cl5'd-(±)-ENBA prevented the increase in sIPSC frequency and eIPSC amplitude produced by SKF. Since exaggerated DA transmission along the striato-nigral pathway is involved in the motor complications (e.g. dyskinesia) caused by prolonged and intermittent administration of l-DOPA, we examined the effect of A1R activation in mice with unilateral DA denervation. We found that 5'Cl5'd-(±)-ENBA, administered in combination with l-DOPA, reduced the development of abnormal involuntary movements. These results indicate the potential benefit of A1R agonists for the treatment of l-DOPA-induced dyskinesia and hyperkinetic disorders providing a mechanistic framework for the study of the interaction between DA and adenosine in the striatonigral system.